As indicated by the release of the China Cardiovascular Health and Disease Report 2019, the current number of cardiovascular patients is 330 million and is still on the rise.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Recently, Sansure Biotech and Thermo Fisher Scientific (hereinafter referred to as: Thermo Fisher) signed a strategic cooperation agreement.The two sides will work together with their respective superior technologies and resources to carry

GenMark Diagnostics announced recently it has received 510(k) clearance from the US Food and Drug Administration for a molecular diagnostic panel assay to detect fungal pathogens from blood cultures of patients with suspected blood stream i

Recently AmoyDx ROS1 gene fusion detection kit (fluorescence PCR method) was approved by Taiwan Food and Drug Administration（TFDA). Prior to this, the AmoyDx ROS1 Gene Fusion Detection Kit has been approved by China NMPA, Japan PMDA and Ko

Foundation Medicine announced recently that its FoundationOne CDx genomic profiling assay has received regulatory approval from Japans Ministry of Health, Labour and Welfare (MHLW). The next-generation sequencing-based assay which was appro

Cepheid announced recently it has received CE-IVD clearance for a rapid molecular assay to measure viral load of hepatitis B in infected patients. The Xpert HBV Viral Load test measures HBV DNA levels in plasma or serum using the firms Gene

French diagnostics firm Novacyt announcedrecentlythat it has received CE marking for its Genesig BK virus (BKV) and Epstein-Barr virus (EBV) diagnostic kits, which are designed for use in post-transplantation and immunosuppressed patients. B

A cell-by-cell search for cardiac stem cells has come up empty, suggesting that previous studies hinting at the existence of cardiac stem cells were mistaken. More significantly, the absence of cardiac stem cells indicates that heart muscle

An innovative new medical instrumentation and biotechnology company known asDaxorjust published some exciting new data for their flagship technology, theBVA-100 blood volume analyzer. The new technology is designed to quantify circulating to

Oxford HighQ has received2.1 millionin seed funding to commercialize components of a quantum computing technology developed at Oxford University that can be used to develop improved chemical and nanoparticle sensing technologies. Oxford High

A long-awaited and massive study with major implications for the liquid biopsy market is slated to start next year. Earlier this week, GRAIL revealed that it would initiate its 50,000-patient SUMMIT study in early 2019. Ages of the patients